Expertise in
8
conditions

Dr. Mark M. Souweidane

Neurosurgery | Pediatrics
1305 York Ave, 9th Floor, 
New York, NY 
Accepting New Patients
Offers Telehealth
Expertise in
8
conditions
1305 York Ave, 9th Floor, 
New York, NY 

Overview

Mark Souweidane is a Pediatrics specialist and a Neurosurgery provider practicing medicine in New York, New York.

Dr. Souweidane is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Gliomatosis Cerebri, Brain Tumor, Medulloblastoma, and Osteotomy.

Dr. Souweidane is board certified in American Board Of Pediatric Neurological Surgery and American Board Of Neurological Surgery. He is actively involved in clinical research, co-authoring 228 peer reviewed articles and participating in 6 clinical trials. Dr. Souweidane is currently accepting new patients.

Specialties

Neurosurgery
Pediatrics

Licenses

Neurological Surgery in NY

Board Certifications

American Board Of Pediatric Neurological Surgery
American Board Of Neurological Surgery

Hospital Affiliations

New York-Presbyterian Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Weill Cornell Medicine Brain & Spine Center
1305 York Ave, 9th Floor, New York, NY 10021

Additional Areas of Focus

Dr. Souweidane has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Brain Tumor
Tethered Cord Syndrome
Chiari Malformation
Arachnoid Cysts
Neurofibromatosis Type 2 (NF2)
Posterior Fossa Tumor
Neurofibromatosis Type 1 (NF1)
Medulloblastoma
Moyamoya Disease
Brain Abscess

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase I Study of Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy
A Phase I Study of Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy
Enrollment Status: Completed
Publish Date: December 19, 2023
Intervention Type: Drug, Radiation
Study Drug: Radioactive iodine-labeled monoclonal antibody omburtamab
Study Phase: Phase 1
An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Drug
Study Phase: Phase 2
Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux (Cetuximab) And Avastin (Bevacizumab)For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age
Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux (Cetuximab) And Avastin (Bevacizumab)For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age
Enrollment Status: Terminated
Publish Date: August 09, 2022
Intervention Type: Drug
Study Drug: SIACI of Erbitux and Bevacizumab
Study Phase: Phase 1/Phase 2
An Open Label Single Arm Phase I/II Study of MTX110 Delivered by Convection-enhanced Delivery (CED) in Patients With Diffuse Intrinsic Pontine Glioma (DIPG) Previously Treated With External Beam Radiation Therapy
An Open Label Single Arm Phase I/II Study of MTX110 Delivered by Convection-enhanced Delivery (CED) in Patients With Diffuse Intrinsic Pontine Glioma (DIPG) Previously Treated With External Beam Radiation Therapy
Enrollment Status: Completed
Publish Date: February 25, 2022
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection
Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection
Enrollment Status: Completed
Publish Date: December 11, 2018
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
Enrollment Status: Completed
Publish Date: July 16, 2018
Intervention Type: Other
View 5 Less Clinical Trials

228 Total Publications

Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi study.
Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi study.
Journal: Journal of neuro-oncology
Published: March 23, 2026
Similar Doctors
Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required

Nyc Health Hospitals / Bellevue

462 1st Ave, 
New York, NY 
 (2.1 miles away)
844-692-4692
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Kondziolka is a Neurosurgery provider practicing medicine in New York, New York. Dr. Kondziolka is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Schwannoma, Acoustic Neuroma, Arteriovenous Malformation, Gamma Knife Radiosurgery, and Endovascular Embolization.

Expertise in
36
conditions
Expertise in
36
conditions
Referral may be required

CUIMC/Neurological Institute Of New York

710 W 168th St, 
New York, NY 
 (5.3 miles away)
347-380-6061
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Bruce is a Neurosurgery provider practicing medicine in New York, New York. Dr. Bruce is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Bruce is currently accepting new patients.

Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

Weill Cornell Medicine Brain & Spine Center

1305 York Ave, 9th Floor, 
New York, NY 
 (0.1 miles away)
212-746-5620
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Theodore Schwartz is a Neurosurgery provider practicing medicine in New York, New York. Dr. Schwartz is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Meningioma, Pituitary Tumor, Craniopharyngioma, Endoscopic Transnasal Transsphenoidal Surgery, and Turbinectomy.

Frequently Asked Questions about Dr. Mark M. Souweidane

How do I make an appointment with Dr. Mark M. Souweidane?

You can book an appointment with Dr. Mark M. Souweidane by calling their office at 212-746-2363. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark M. Souweidane a top-rated expert for Diffuse Midline Glioma H3 K27M-Mutant?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark M. Souweidane is classified as an Elite expert for Diffuse Midline Glioma H3 K27M-Mutant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark M. Souweidane specialize in?

While Dr. Mark M. Souweidane is a Neurosurgery, they have specific expertise in Diffuse Midline Glioma H3 K27M-Mutant, Gliomatosis Cerebri, and Brain Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Mark M. Souweidane participate in research or clinical trials?

Yes. Dr. Mark M. Souweidane has published 228 articles and abstracts on conditions like Diffuse Midline Glioma H3 K27M-Mutant. You can view a list of Dr. Mark M. Souweidane's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark M. Souweidane accept my insurance?

Dr. Mark M. Souweidane accepts most major insurance plans, including Aetna and Humana. We recommend calling the office directly at 212-746-2363 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Souweidane's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile